Lab21

Cambridge, United Kingdom Founded: 2005 • Age: 21 yrs Acquired By Novacyt
Personalised diagnostic testing for diseases and predisposition is specialised in.
Request Access

About Lab21

Lab21 is a company based in Cambridge (United Kingdom) founded in 2005 by Graham Mullis was acquired by Novacyt in May 2014.. Lab21 has raised $837.8 thousand across 1 funding round from investors including Trinity Biotech and Novacyt. Lab21 has completed 1 acquisition, including Selah Technologies.

  • Headquarter Cambridge, United Kingdom
  • Founders Graham Mullis
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name The Lab21 Ltd
  • Date of Incorporation 29 Dec, 2020
  • Jurisdiction BUSHEY, ENGLAND
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $837.8 K (USD)

    in 1 rounds

  • Latest Funding Round
    $837.8 K (USD), Seed

    Oct 26, 2010

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Novacyt

    & 1 more

    (May 27, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lab21

Lab21 has successfully raised a total of $837.8K through 1 strategic funding round. The most recent funding activity was a Seed round of $837.8 thousand completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Seed — $837,800
  • First Round

    (26 Oct 2010)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2010 Amount Seed - Lab21 Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lab21

Lab21 has secured backing from 2 investors. Prominent investors backing the company include Trinity Biotech and Novacyt. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Provider of In vitro diagnostic kits for clinical labs
Founded Year Domain Location
Developer of cytology instruments and consumables for oncology and infectious disease
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lab21

Lab21 has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Selah Technologies. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Nano-enabled advanced materials are manufactured using proprietary nanotechnology products.
2006
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Lab21

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lab21 Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lab21

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lab21

Frequently Asked Questions about Lab21

When was Lab21 founded?

Lab21 was founded in 2005 and raised its 1st funding round 5 years after it was founded.

Where is Lab21 located?

Lab21 is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Is Lab21 a funded company?

Lab21 is a funded company, having raised a total of $837.8K across 1 funding round to date. The company's 1st funding round was a Seed of $837.8K, raised on Oct 26, 2010.

What does Lab21 do?

Lab21 was founded in 2005 in Cambridge, United Kingdom, within the personalised medicine diagnostics sector. Molecular testing services for cancer and virology diagnosis, along with treatment optimisation, are offered to patients. Proprietary antibodies and antigens for infectious diseases such as syphilis, CMV, TB, and malaria are manufactured. These products are distributed globally to blood banking and diagnostic markets.

How many acquisitions has Lab21 made?

Lab21 has made 1 acquisition, including Selah Technologies.

Who are Lab21's investors?

Lab21 has 2 investors. Key investors include Trinity Biotech, and Novacyt.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available